The UPenn PRC has received $1.4 million from the Centers for Disease Control and Prevention (CDC) for three new Special Interest Projects (SIPs).  In addition to the core funding which started the Center, the UPenn PRC has received a total of seven supplements in funding during its first two years, totaling $5.4 million.

The three new projects include The Philadelphia Health Leadership Institute (SIP #15-006), a two-year initiative that aims to build local community health leadership to prevent chronic disease, led by Principal Investigator Frances Barg, Ph.D, a medical anthropologist and an associate professor in the department of Family Medicine and Community Health.

Another is a three-year funded project (SIP #15-001) led by Christine Hill-Kayser, an assistant professor of Radiation Oncology, and Lisa Schwartz, PhD, an assistant professor of clinical psychology in Pediatrics at The Children’s Hospital of Philadelphia, that tests the impact of a technology-based intervention that will provide customized care plans and a tailored mobile health application to help adolescents and young adults who are childhood cancer survivors take a greater role in managing their health.

The third, led by Marilyn Schapira, MD, MPH, an associate professor of medicine at the Corporal Michael J. Crescenz Veteran’s Administration Medical Center and co-leader of the Cancer Control Research Program at the Abramson Cancer Center,  is a two-year effort (SIP #15-002) that will compare the economic impact and health-related quality of life outcomes among children with cancer who were treated in phase III clinical trials to those who received non-trial standard treatment. Understanding the costs of treatment associated with clinical trial participation is critical in determining if the effects of treatment justify the costs from a societal perspective, including costs borne by the patient and family.

The UPenn PRC is the first Prevention Research Center in Pennsylvania and one of 26 CDC-funded PRCs nationwide.


To read more, go to: